Search
N-Formylmethionine
go.drugbank.com/drugs/DB04464ExperimentalThis process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells. … N-Formylmethionine is effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA.
Synonyms: N-Formylmethionine, L-N-Formylmethionine5-Methoxy-N,N-diisopropyltryptamine
go.drugbank.com/drugs/DB01441ExperimentalIllicit5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, … N,N-diethyltryptamine, bufotenine, psilocybin and psilocin.
Synonyms: 5-Methoxy-N,N-diisopropyltryptamine, 5-methoxy-N,N-bis(1-methylethyl)-1H-indole-3-ethanamineUrolithin A
go.drugbank.com/drugs/DB15464ExperimentalIt has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging.[A179494]
(5E,7E,9)-decatrien-2-one
go.drugbank.com/drugs/DB15618ExperimentalAn compound produced by _Fomitopsis betulina_, an edible fungus commonly called the birch polypore. Similar to [(5Z,7E,9)-decatrien-2-one], it has a strong pineapple aroma.[A191116]
Micronomicin
go.drugbank.com/drugs/DB13274ApprovedMicronomicin is an aminoglycoside antibiotic which is marketed in Japan, and sold under the brand names Sagamicin and Luxomicina.
Osanetant
go.drugbank.com/drugs/DB04872InvestigationalDeveloped by Sanofi-Aventis (formerly Sanofi-Synthelabo), osanetant (SR-142801) is an NK3 receptor antagonist which was under development for the treatment of schizophrenia and other Central Nervous System … In a review of its R&D portfolio, the company announced in August 2005 that it would cease any further development of osanetant.
SAR445136
go.drugbank.com/drugs/DB17708InvestigationalHbF production in erythrocytes (RBC). … [A259063] It was formerly investigated for the treatment of beta-thalassemia, and it is currently being investigated for the treatment of sickle cell disease.[L46148]
Conatumumab
go.drugbank.com/drugs/DB11646InvestigationalConatumumab has been used in trials studying the treatment of Sarcoma, Lymphoma, Oncology, Colon Cancer, and Rectal Cancer, among others.
Epacadostat
go.drugbank.com/drugs/DB11717InvestigationalEpacadostat has been used in trials studying the treatment of HL, Melanoma, Glioblastoma, Mucosal Melanoma, and Ovarian Carcinoma, among others.
Emicerfont
go.drugbank.com/drugs/DB12910InvestigationalEmicerfont has been used in trials studying the diagnostic and treatment of Social Anxiety Disorder and Irritable Bowel Syndrome (IBS).